Onassis Holdings Taps International Law Expert to Fuel Biotech Expansion

NEW YORK – November 5, 2025 – Onassis Holdings Corp (OTC: ONSS), a US-based biotechnology company pioneering cellular rejuvenation and longevity therapies, has appointed Esq. Paz Itzhaki-Weinberger to its Advisory Board, signaling a strategic push towards international expansion. The move underscores the increasing importance of navigating complex global regulations and securing intellectual property in the rapidly evolving biotech landscape.

Itzhaki-Weinberger will lead the company’s strategy on international law, trade, and cross-border corporate affairs. A veteran of both the technology and legal worlds, he brings a unique blend of expertise to Onassis Holdings, a company focused on bringing regenerative medicine innovations to the global market.

“The biotechnology sector is becoming increasingly globalized,” explains a source familiar with the company’s strategy. “Success hinges on not only scientific breakthroughs but also the ability to navigate a complex web of international regulations, protect intellectual property, and forge strategic partnerships. Paz’s background is perfectly suited to address these challenges.”

A Convergence of Tech & Law

Itzhaki-Weinberger’s career spans decades, beginning with a strong technical foundation. He holds degrees in both Computer Science and Law, a combination increasingly sought after in the biotech sector. He previously held senior roles at Microsoft Corporation and founded PIWLAW, recognized among the Top 200 Law Firms Worldwide from 2014-2025. The firm specializes in technology law and intellectual property, with a strong international focus.

“The intersection of technology and law is critical in the biotechnology space,” says an industry analyst who requested anonymity. “Protecting novel therapies and ensuring compliance with diverse regulatory frameworks requires a deep understanding of both the science and the legal landscape. Someone who understands the technology and can translate that into legal strategy is invaluable.”

Currently, Itzhaki-Weinberger serves as CEO & Chairman of IWC Limited, a company specializing in intellectual property management and technology transfer. He also founded PatentsFund.com, a platform connecting inventors with investors to fund patent development. This experience positions him well to guide Onassis Holdings through the complexities of international patent filings and licensing agreements.

Strategic Expansion & Competitive Landscape

Onassis Holdings’ appointment of Itzhaki-Weinberger comes as the company appears poised for international growth. Recent filings reveal that the company has filed numerous international patents related to its cellular rejuvenation technologies, protecting its innovations in key global markets. The company has also announced partnerships with research institutions in Europe and Asia, indicating a deliberate effort to expand its reach beyond the United States.

The cellular rejuvenation and longevity market is becoming increasingly competitive. Companies like Altos Labs, Calico, and BioViva are all vying for a share of the market, and international expansion is often a key component of their strategies. This requires careful navigation of regulatory hurdles in various countries.

“The regulatory landscape for biotechnology varies significantly from country to country,” explains a legal expert specializing in international biotech regulations. “What’s approved in the United States may not be approved elsewhere, and the process for obtaining approval can be lengthy and complex. Having someone on the Advisory Board who understands these nuances is essential.”

Intellectual Property & Global Strategy

Protecting intellectual property is paramount in the biotech industry. With the high cost of research and development, companies must ensure their innovations are protected from competition. Itzhaki-Weinberger’s expertise in intellectual property law will be crucial for Onassis Holdings as it expands into new markets.

“Global IP strategy is no longer just about obtaining patents,” says a source close to the company. “It’s about enforcing those patents in multiple jurisdictions, navigating licensing agreements, and protecting trade secrets. Paz’s experience in these areas will be invaluable.”

IWC Limited, Itzhaki-Weinberger’s current company, plays a key role in bridging the gap between innovation and commercialization. This expertise will likely be leveraged to help Onassis Holdings translate its scientific breakthroughs into commercially viable products.

Looking Ahead

The appointment of Paz Itzhaki-Weinberger signals a strategic shift for Onassis Holdings, one focused on international expansion and intellectual property protection. As the company embarks on this new chapter, its ability to navigate the complexities of the global biotech landscape will be critical to its success. The intersection of legal and technical expertise embodied by Itzhaki-Weinberger positions Onassis Holdings for continued growth and innovation in the rapidly evolving field of cellular rejuvenation and longevity.